Structural Biology & Molecular Modeling Techniques Market Worth $13.1 Billion By 2025: Grand View Research, Inc.

Monday, January 30, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, January 30, 2017 /PRNewswire/ --

The structural biology & molecular modeling techniques market

 is expected to reach USD 13.1 billion by 2025, according to a new study by Grand View Research, Inc. An unprecedented rise in the adoption of unhealthy lifestyles has led to an upsurge in the prevalence of chronic
diseases, such as diabetes and cancer, which is presumed to propel the structural biology & molecular modeling techniques market during the forecast period.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757 )

Moreover, increasing drug resistance coupled with the high drug attrition rate is engendering the requirement for extensive R&D activities, which is presumed to boost the adoption of structural biology & molecular modeling techniques in the drug discovery and development process. This is expected to serve as an efficient approach in fast tracking the development of drugs with high potency.

The heightening demand for molecular modeling techniques is predominantly attributable to the significant cost reduction enabled. This is due to the fact that prediction software identifies possible adverse reactions and determines drug efficacy and toxicity in the pre-clinical stages, thereby reducing the probability of drug failure at the later stages. Consequentially, the aforementioned factors serve as prominent reasons responsible for the widened market demand.

Browse full research report with TOC on "Structural Biology & Molecular Modeling Techniques Market Analysis By Tools (SaaS & Standalone Modeling, Homology Modeling, Threading, Molecular Dynamics, Ab Initio, Visualization & Analysis, Databases), By Application, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/structural-biology-and-molecular-modeling-technique-market

Further key findings from the study suggest: 

  • SaaS & standalone modeling held the largest share of the tools segment in 2015 owing to extensive utilization of computer-assisted structuring and modeling techniques in R&D
  • The drug discovery segment is anticipated to grow at a lucrative CAGR owing to continual introduction of software modifications with focus on enhanced drug designing aimed to accelerate the process in identifying novel therapeutic agents
  • In 2015, North America dominated the global structural biology & molecular modeling techniques market owing to the presence of a wide number of established pharmaceutical companies extensively involved in the commercialization of in silico tools to promote their usage
  • Asia Pacific is expected to grow at an exponential CAGR owing to favorable government initiatives supporting research activities and the increasing trend of outsourcing drug development by the developed economies
  • The key participants are employing clinical and research collaborative strategies promoting the adoption of structural prediction software and databases to gain a competitive advantage

Browse related reports by Grand View Research: 

  • Pneumonia Market - http://www.grandviewresearch.com/industry-analysis/pneumonia-market
  • High Content Screening Market - http://www.grandviewresearch.com/industry-analysis/high-content-screening-market
  • Pulmonary Drug Delivery Systems Market - http://www.grandviewresearch.com/industry-analysis/pulmonary-drug-delivery-systems-market
  • Spinal Non Fusion Technologies Market - http://www.grandviewresearch.com/industry-analysis/spinal-non-fusion-technologies-market

Grand View Research has segmented the structural biology & molecular modeling techniques market on the basis of tools, applications, and region: 

  • Tools Outlook (Revenue, USD Million, 2014 - 2025) 
    • SaaS & standalone modeling
      • Homology modeling
      • Threading
      • Molecular dynamics
      • Ab Initio
      • Hybrid
      • Others
    • Visualization & analysis
    • Databases
    • Others
  • Application Outlook (Revenue, USD Million, 2014 - 2025) 
    • Drug development
    • Drug discovery
    • Others
  • Regional Outlook (Revenue, USD Billion, 2014 - 2025) 
    • North America
      • U.S.
      • Canada
    • Europe
      • UK
      • Germany
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Mexico
      • Brazil
    • MEA
      • South Africa

Read Our Blogs - Structural biology & molecular modeling techniques: Advanced technology to aid in drug discovery process

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.grandviewresearch.com

SOURCE Grand View Research, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store